ARCHIVES

Crout Resigns As Director Of FDA Drugs Bureau

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

Other DCT Concepts Approved By Board

February 26, 1988

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

NCAB Committee, SORDS Agree On New Training Grants In Surgical Oncology

January 11, 1985

Final Money Bill Clear On Permitting New Construction Funding

December 12, 1975

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006